BSE
MARKET ANALYSIS NEWS CORPORATE INFORMATION CORPORATE ACTIONS OTHER MARKETS
Your Result on : Company News Details
Dr Lal Pathlabs Ltd Industry :  Healthcare
BSE Code
539524
ISIN Demat
INE600L01024
Book Value (Rs)
147.5167422
NSE Symbol
LALPATHLAB
Divident Yield %
1.48
Market Cap
(Rs In Cr.)
27,689
P/E (TTM)
52.1
EPS (TTM)
31.7
Face Value
(Rs)
10
Back
Dr Lal Pathlabs consolidated net profit declines 15.18% in the March 2026 quarter
30-Apr-26   Hrs IST

Net profit of Dr Lal Pathlabs declined 15.18% to Rs 131.30 crore in the quarter ended March 2026 as against Rs 154.80 crore during the previous quarter ended March 2025. Sales rose 16.61% to Rs 702.70 crore in the quarter ended March 2026 as against Rs 602.60 crore during the previous quarter ended March 2025.

For the full year,net profit rose 3.63% to Rs 504.80 crore in the year ended March 2026 as against Rs 487.10 crore during the previous year ended March 2025. Sales rose 12.25% to Rs 2762.90 crore in the year ended March 2026 as against Rs 2461.40 crore during the previous year ended March 2025.

ParticularsQuarter EndedYear Ended
Mar. 2026Mar. 2025% Var.Mar. 2026Mar. 2025% Var.
Sales702.70602.60 17 2762.902461.40 12
OPM %26.5828.05 -28.3228.26 -
PBDT204.70189.80 8 861.00766.60 12
PBT160.10153.40 4 699.20624.70 12
NP131.30154.80 -15 504.80487.10 4

Risk Factor   |   Terms & Conditions   |   Privacy Policy   |   Disclaimer   |  Sitemap 
Important Links:   SEBI   |   NSE   |   BSE   |   MCX   |   NCDEX   |   NSDL   |   CDSL  |   FMC
SMS FINANCIAL SERVICES P. LTD -NSE SEBI No. AP1413004363 | BSE SEBI No. AP01091801121968
Ganesh S Shanbhag – AMFI Registered Mutual Fund Distributor. Registration Number – ARN-0988 – Valid Till 01/JUL/ 2027, Date of initial registration: 02/DEC/2004
2017-18 © SMS Financial Services. All rights reserved. Designed, Developed and Maintained by CMOTS InfoTech (ISO 9001:2015 & ISO/IEC 27001:2022 Certified)